TURRIZIANI, FABRIZIO
 Distribuzione geografica
Continente #
EU - Europa 337
NA - Nord America 147
AS - Asia 111
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 7
AF - Africa 2
Totale 618
Nazione #
RU - Federazione Russa 203
US - Stati Uniti d'America 146
IT - Italia 64
SG - Singapore 35
IE - Irlanda 27
CN - Cina 20
VN - Vietnam 19
DE - Germania 15
HK - Hong Kong 15
IN - India 10
GB - Regno Unito 8
BR - Brasile 7
KR - Corea 5
FR - Francia 4
JP - Giappone 4
NL - Olanda 4
CZ - Repubblica Ceca 3
FI - Finlandia 3
AT - Austria 2
DK - Danimarca 2
TR - Turchia 2
GR - Grecia 1
GT - Guatemala 1
MY - Malesia 1
PL - Polonia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 604
Città #
Moscow 78
San Jose 32
Dublin 27
Naples 27
Singapore 17
Hong Kong 15
Santa Clara 14
Chandler 10
Dallas 10
Ashburn 9
Bari 8
Bengaluru 8
Ho Chi Minh City 8
Council Bluffs 7
Hanoi 7
Munich 7
Hefei 6
Napoli 6
The Dalles 6
Seoul 5
Milan 4
Amsterdam 3
Bremen 3
Brno 3
Cambridge 3
Ercolano 3
Princeton 3
Roxbury 3
Turku 3
Columbus 2
Hải Dương 2
Istanbul 2
Juelsminde 2
Maddaloni 2
Massa 2
New York 2
North Bergen 2
São Paulo 2
Athens 1
Beijing 1
Belfast 1
Bexley 1
Biên Hòa 1
Brooklyn 1
Caivano 1
Caserta 1
Castelsardo 1
Cedar Hill 1
Chennai 1
Chula Vista 1
Clementon 1
Esmeraldas 1
Falkenstein 1
Frankfurt am Main 1
Grand Junction 1
Guangzhou 1
Guatemala City 1
Itabuna 1
Itupeva 1
Jouy-aux-Arches 1
Kempton Park 1
L'aquila 1
Lehigh Acres 1
Los Angeles 1
Lynchburg 1
Miano 1
Monza 1
New Delhi 1
Newark 1
Nuremberg 1
Orem 1
Phoenix 1
Princé 1
Puchong Batu Dua Belas 1
San Francisco 1
Sarno 1
Selargius 1
Shenzhen 1
Taiyuan 1
Tampa 1
Tijucas 1
Tokyo 1
Tunis 1
Votorantim 1
Vũng Tàu 1
Warsaw 1
Wilmington 1
Totale 402
Nome #
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 196
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 145
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 140
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator 137
Totale 618
Categoria #
all - tutte 1.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 0 5 6 8 2 2 3 0 6
2022/202346 4 2 2 3 3 3 0 2 25 0 1 1
2023/202442 3 18 4 1 6 4 0 1 0 0 1 4
2024/202588 4 1 0 2 7 9 12 5 13 4 7 24
2025/2026346 19 25 19 9 33 180 15 23 8 9 4 2
2026/202758 3 9 13 33 0 0 0 0 0 0 0 0
Totale 618